{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:07:19Z","timestamp":1765976839866,"version":"build-2065373602"},"reference-count":37,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Metabolic syndrome (MetS) is considered a global epidemic, and its diagnosis is crucial, allowing early intervention and management. The main aim of this study was to examine any possible blood pressure (BP) differences based on office and out-of-office measurements in patients with and without MetS, and to investigate if any of these measurements correlated better with MetS. The secondary aim was to investigate any possible cardiovascular risk differences. Materials and Methods: The study population consisted of individuals attending the outpatient hypertension clinic. Office and out-of-office BP measurements were recorded in all of the patients, as well as different cardiovascular risk scores and echocardiography. MetS was defined according to ACC\/AHA criteria. Results: A total of 282 (39.9% men) individuals (56.8 \u00b1 15.8 years) were analyzed; 60.8% of them had MetS. The patients with MetS had a significantly higher systolic BP (SBP) in all of the BP measurements, higher ASCVD risk (22% vs. 12%), Framingham risk scores (11.8% vs. 6.9%), a significantly higher prevalence of LVH (49.2% vs. 22.7%) and early vascular aging (54.8% vs. 27.4%) compared with the patients without MetS (p &lt; 0.05 for all). In a univariate analysis, MetS was significantly correlated with the average 24h SBP, daytime and nighttime ambulatory SBP, office SBP, and home SBP in the morning (p &lt; 0.05). No significant differences were observed for any of the DBP measurements. Finally, 50.5% of the MetS patients had sustained hypertension, 15.2% masked hypertension, and 11.5% white-coat hypertension based on ABPM, and these values were 45.1%, 19.3%, and 13.6%, respectively, based on HBPM. Furthermore, most of the MetS patients had non-dipping hypertension (56.4%). Conclusions: The present findings highlight the importance of out-of-office BP measurements in the diagnosis of MetS, since both a high office and out-of-office SBP were significant features of the syndrome (whereas this was not the case with DBP). This is further supported by the increased prevalence of different hypertension phenotypes observed in the MetS patients. Higher ASCVD risk scores and LVH and EVA prevalence were also related to MetS, thus strongly supporting the necessity for early detection and treatment.<\/jats:p>","DOI":"10.3390\/medicina61030434","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T06:45:42Z","timestamp":1740725142000},"page":"434","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5164-7435","authenticated-orcid":false,"given":"Christina","family":"Antza","sequence":"first","affiliation":[{"name":"3rd Department of Internal Medicine, Aristotle University, Hypertension, Hypertension-24h Ambulatory Blood Pressure Monitoring Center, Papageorgiou Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Sitmalidou","sequence":"additional","affiliation":[{"name":"3rd Department of Internal Medicine, Aristotle University, Hypertension, Hypertension-24h Ambulatory Blood Pressure Monitoring Center, Papageorgiou Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7848-6600","authenticated-orcid":false,"given":"Andrej","family":"Belan\u010di\u0107","sequence":"additional","affiliation":[{"name":"Department of Basic and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-2644","authenticated-orcid":false,"given":"Niki","family":"Katsiki","sequence":"additional","affiliation":[{"name":"Department of Nutritional Sciences and Dietetics, International Hellenic University, 57400 Thessaloniki, Greece"},{"name":"School of Medicine, European University Cyprus, Nicosia 2404, Cyprus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-8097","authenticated-orcid":false,"given":"Vasilios","family":"Kotsis","sequence":"additional","affiliation":[{"name":"3rd Department of Internal Medicine, Aristotle University, Hypertension, Hypertension-24h Ambulatory Blood Pressure Monitoring Center, Papageorgiou Hospital, 56429 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s42000-018-0074-9","article-title":"Metabolic syndrome: Joint diagnostic criteria and links with comorbidities","volume":"18","author":"Katsiki","year":"2019","journal-title":"Hormones"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome--a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCULATIONAHA.108.191394","article-title":"Progress and challenges in metabolic syndrome in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism","volume":"119","author":"Steinberger","year":"2009","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J. Hypertens."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/1440-1681.12114","article-title":"White-coat hypertension","volume":"41","author":"Martin","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/HYPERTENSIONAHA.120.14591","article-title":"Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension","volume":"77","author":"Huang","year":"2021","journal-title":"Hypertension"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40885-024-00265-w","article-title":"When and how to use ambulatory blood pressure monitoring and home blood pressure monitoring for managing hypertension","volume":"30","author":"Lee","year":"2024","journal-title":"Clin. Hypertens."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ajh\/hpy160","article-title":"The Effectiveness of Home Blood Pressure on 24-Hour Blood Pressure Control: A Randomized Controlled Trial","volume":"32","author":"Cuffee","year":"2019","journal-title":"Am. J. Hypertens."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HJH.0000000000003557","article-title":"Ambulatory and home blood pressure monitoring for cardiovascular disease risk evaluation: A systematic review and meta-analysis of prospective cohort studies","volume":"42","author":"Panagiotakos","year":"2024","journal-title":"J. Hypertens."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.jacc.2020.10.039","article-title":"Reliability of Office, Home, and Ambulatory Blood Pressure Measurements and Correlation With Left Ventricular Mass","volume":"76","author":"Schwartz","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00125-009-1327-6","article-title":"Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes","volume":"52","author":"Marcovecchio","year":"2009","journal-title":"Diabetologia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/ajh\/hpy115","article-title":"Early Vascular Aging Risk Assessment From Ambulatory Blood Pressure Monitoring: The Early Vascular Aging Ambulatory Score","volume":"31","author":"Antza","year":"2018","journal-title":"Am. J. Hypertens."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41371-024-00909-2","article-title":"Non-dipping blood pressure pattern is associated with cardiovascular events in a 21-year follow-up study","volume":"38","author":"Ylitalo","year":"2024","journal-title":"J. Hum. Hypertens."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"i4098","DOI":"10.1136\/bmj.i4098","article-title":"Blood pressure variability and cardiovascular disease: Systematic review and meta-analysis","volume":"354","author":"Stevens","year":"2016","journal-title":"BMJ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/HJH.0000000000002246","article-title":"Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure","volume":"38","author":"Sharman","year":"2020","journal-title":"J. Hypertens."},{"key":"ref_18","unstructured":"National Institutes of Health (1998). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. Obes. Res., 6, 51s\u2013209s."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1038\/ijo.2008.247","article-title":"WHO recognition of the global obesity epidemic","volume":"32","author":"James","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"100335","DOI":"10.1016\/j.ajpc.2022.100335","article-title":"Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement","volume":"10","author":"Wong","year":"2022","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_22","unstructured":"(2024). Introduction and Methodology: Standards of Care in Diabetes-2024. Diabetes Care, 47, S1\u2013S4."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ahj.2007.02.027","article-title":"Prediction of first coronary events with the Framingham score: A systematic review","volume":"153","author":"Eichler","year":"2007","journal-title":"Am. Heart. J."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"(2010). Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'Establishing normal and reference values\u2019. Eur. Heart J., 31, 2338\u20132350.","DOI":"10.1093\/eurheartj\/ehq165"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0895-7061(01)02326-3","article-title":"Clinical applications of arterial stiffness, Task Force III: Recommendations for user procedures","volume":"15","author":"Duprez","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/HJH.0b013e32834fa8b0","article-title":"Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity","volume":"30","author":"Laurent","year":"2012","journal-title":"J. Hypertens."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2005.03.070","article-title":"Prognosis of \u201cmasked\u201d hypertension and \u201cwhite-coat\u201d hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study","volume":"46","author":"Ohkubo","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/01.HYP.0000152079.04553.2c","article-title":"Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: The ohasama study","volume":"45","author":"Kikuya","year":"2005","journal-title":"Hypertens."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/jch.12974","article-title":"Metabolic syndrome and masked hypertension among African Americans: The Jackson Heart Study","volume":"19","author":"Colantonio","year":"2017","journal-title":"J. Clin. Hypertens."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1161\/hc3701.096100","article-title":"Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study)","volume":"104","author":"Sega","year":"2001","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11906-013-0348-1","article-title":"The Pamela study: Main findings and perspectives","volume":"15","author":"Bombelli","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/07420528.2011.580871","article-title":"Relationship between metabolic syndrome, circadian treatment time, and blood pressure non-dipping profile in essential hypertension","volume":"28","author":"Hermida","year":"2011","journal-title":"Chronobiol. Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1620\/tjem.210.57","article-title":"Metabolic syndrome as a predictor of non-dipping hypertension","volume":"210","author":"Tartan","year":"2006","journal-title":"Tohoku. J. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/jch.14039","article-title":"Nighttime dipping status and risk of cardiovascular events in patients with untreated hypertension: A systematic review and meta-analysis","volume":"22","author":"Gavriilaki","year":"2020","journal-title":"J. Clin. Hypertens."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12933-020-01166-6","article-title":"Risk for cardiovascular disease associated with metabolic syndrome and its components: A 13-year prospective study in the RIVANA cohort","volume":"19","author":"Guembe","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/15701611113119990131","article-title":"Characteristics other than the diagnostic criteria associated with metabolic syndrome: An overview","volume":"12","author":"Katsiki","year":"2014","journal-title":"Curr. Vasc. Pharmacol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/3\/434\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:44:34Z","timestamp":1760028274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/3\/434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["medicina61030434"],"URL":"https:\/\/doi.org\/10.3390\/medicina61030434","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}